Endometrial cancer secondary prevention: Difference between revisions

	Endometrial cancer Microchapters
Home
Patient Information
Overview
Historical perspective
Classification
Pathophysiology
Causes
Differentiating Endometrial cancer from other Diseases
Epidemiology and Demographics
Risk factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Endometrial cancer secondary prevention On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Endometrial cancer secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Endometrial cancer secondary prevention
CDC on Endometrial cancer secondary prevention
Endometrial cancer secondary prevention in the news
Blogs on Endometrial cancer secondary prevention
Directions to Hospitals Treating Endometrial cancer
Risk calculators and risk factors for Endometrial cancer secondary prevention

VisualWikitext

Latest revision as of 16:52, 29 November 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]

Overview

There are no established measures for the secondary prevention of endometrial cancer.

Secondary Prevention

There are no established measures for the secondary prevention of endometrial cancer.

References

Template:WikiDoc Sources

@@ Line 3: / Line 3: @@
 {{CMG}}{{AE}}{{MD}}
 ==Overview==
-The risk of recurrence of endometrial cancer is highest within 2 years. Life-time follow-up is needed, especially within the first 2 years following diagnosis and successful treatment. Routine follow-up visists occur at 3-4 months interval during the first 2 years, at 6 months interval during the next 3 years, and yearly thereafter.
+There are no established measures for the secondary prevention of endometrial cancer.
 ==Secondary Prevention==
-The risk of recurrence of endometrial cancer is highest within 2 years. Life-time follow-up is needed, especially within the first 2 years following diagnosis and successful treatment.<ref> Follow-up after treatment for uterine cancer. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/uterine/treatment/follow-up/?region=ns. URL Accessed on  September, 22 2015</ref>
+There are no established measures for the secondary prevention of endometrial cancer.
-. Follow-up visits are routinely scheduled as shown below:
-:* Every 3–4 months during the first 2 years
-:* Every 6 months during the next 3 years
-:* Yearly thereafter
-. Follow-up visit includes:
-:* Complete [[physical examination]]
-:* Pelvic examination
-::* Inguinal nodes
-::* [[Pap test]] to detect cancer cells in the upper vagina
-. The following test are recommended to check for recurrence:
-:* [[Chest x-ray]] may be done yearly
-:* [[CT scan]] may be done if the woman has symptoms or something is found during the examination
-:* Serum concentration of cancer antigen 125 (CA125) may be checked for abrupt elevations
-. If a recurrence is detected during follow-up, a thorough oncological reassessment is required for adequate management.
 ==References==

Endometrial cancer secondary prevention: Difference between revisions

Latest revision as of 16:52, 29 November 2018

Overview

Secondary Prevention

References

Navigation menu